26 August – Webinar in connection with year-end report
Alligator invites to a webinar and conference call for investors, analysts, and media, where CEO Søren Bregenholt and CFO Johan Giléus will present and comment on the upcoming interim report. The presentation will be followed by a Q&A session.
The call will be held in English and questions can be submitted in advance via ir@alligatorbioscience.com.
LATEST NEWS
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
Today, on 26 August 2026, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follows …
Alligator Bioscience AB reports financial results for the period 1 January – 30 June 2026 and provides a business update
Strategic refocus: After the quarter, Alligator discontinued all further independent development of mitazalimab and refocused on preserving …
Invitation to Alligator Bioscience’s earnings call on 26 August 2026
Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company whose principal asset is a financial interest i …